EASI Revenue and Competitors
Estimated Revenue & Valuation
- EASI's estimated annual revenue is currently $200.3M per year.
- EASI's estimated revenue per employee is $240,800
Employee Data
- EASI has 832 Employees.
- EASI grew their employee count by -23% last year.
EASI Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $200.3M | 832 | -23% | N/A | N/A |
#2 | $28M | 148 | 26% | N/A | N/A |
#3 | $53.9M | 285 | 48% | N/A | N/A |
#4 | $6.2M | 45 | 25% | N/A | N/A |
#5 | $4.7M | 34 | 10% | N/A | N/A |
#6 | $6.3M | 46 | 12% | N/A | N/A |
#7 | $253.3M | 1052 | 89% | N/A | N/A |
#8 | $10.4M | 67 | 8% | N/A | N/A |
#9 | $5.8M | 42 | 5% | N/A | N/A |
#10 | $1.4M | 14 | -46% | N/A | N/A |
What Is EASI?
Business Services
keywords:N/AN/A
Total Funding
832
Number of Employees
$200.3M
Revenue (est)
-23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
EASI News
2022-04-20 - Global Cardiac Holter Monitor Market Analysis/Forecasts 2022-2027: Industry
Trends, Share, Growth, Insights, Impact of COVID-19, Company Analysis -
ResearchAndMarkets.com
Five EASI electrodes collect three channels of derived 12-Lead ECG, allowing for quick access to high-quality patient data and extending the...
2022-04-19 - Global Virgin Human Hair Market 2022 Major Growth and Top ...
Rebecca; Great Lengths; Hair Dreams; Easi Hair; Balmain; Donna Bella; Cinderella; Socap; Anhui Jinruixiang; Ruimei; Evergreen Products Group; Hairlocs...
2022-04-06 - LEO Pharma Presents New Interim Long-Term Efficacy Data for Adbry
(tralokinumab-ldrm) in Moderate-to-Severe Atopic Dermatitis at the 2022 RAD
Conference
In patients who completed 3 years of treatment with Adbry, the median Eczema Area and Severity Index (EASI) score improved by 93% (2.0 at 3...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $453.7M | 988 | 22% | N/A |
#2 | $75M | 1230 | 4% | N/A |
#3 | $505M | 1582 | 21% | N/A |
#4 | $496.3M | 2954 | -1% | N/A |
#5 | $517.3M | 3079 | -4% | N/A |